These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6272989

  • 1. Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer.
    Eisman JA, Suva LJ, Sher E, Pearce PJ, Funder JW, Martin TJ.
    Cancer Res; 1981 Dec; 41(12 Pt 1):5121-4. PubMed ID: 6272989
    [Abstract] [Full Text] [Related]

  • 2. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
    Findlay DM, Michelangeli VP, Eisman JA, Frampton RJ, Moseley JM, MacIntyre I, Whitehead R, Martin TJ.
    Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
    [Abstract] [Full Text] [Related]

  • 3. Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers.
    Eisman JA, Suva LJ, Martin TJ.
    Cancer Res; 1986 Oct; 46(10):5406-8. PubMed ID: 3019526
    [Abstract] [Full Text] [Related]

  • 4. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.
    Frampton RJ, Suva LJ, Eisman JA, Findlay DM, Moore GE, Moseley JM, Martin TJ.
    Cancer Res; 1982 Mar; 42(3):1116-9. PubMed ID: 6277475
    [Abstract] [Full Text] [Related]

  • 5. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices.
    Freake HC, Abeyasekera G, Iwasaki J, Marcocci C, MacIntyre I, McClelland RA, Skilton RA, Easton DF, Coombes RC.
    Cancer Res; 1984 Apr; 44(4):1677-81. PubMed ID: 6322984
    [Abstract] [Full Text] [Related]

  • 6. 1,25-dihydroxyvitamin D3 and breast cancer.
    Eisman JA, Suva LJ, Frampton RJ.
    Aust N Z J Surg; 1984 Feb; 54(1):17-20. PubMed ID: 6326729
    [Abstract] [Full Text] [Related]

  • 7. Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer.
    Berger U, Wilson P, McClelland RA, Colston K, Haussler MR, Pike JW, Coombes RC.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6793-9. PubMed ID: 2824042
    [Abstract] [Full Text] [Related]

  • 8. Systematic search for 1 alpha,25-dihydroxy-vitamin D3 receptors in human breast carcinomas.
    Ulmann A, Brami M, Corcos D, Bader C, Delarue JC, Contesso G.
    Biomed Pharmacother; 1984 Dec 15; 38(4):204-8. PubMed ID: 6093907
    [Abstract] [Full Text] [Related]

  • 9. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW, Sergeev IN, Bishop JE, Okamura WH.
    Cancer Res; 1993 Sep 01; 53(17):3935-42. PubMed ID: 8395333
    [Abstract] [Full Text] [Related]

  • 10. Normal and malignant breast tissue is a target organ for 1,25-(0H)2 vitamin D3.
    Eisman JA, Macintyre I, Martin TJ, Frampton RJ, King RJ.
    Clin Endocrinol (Oxf); 1980 Sep 01; 13(3):267-72. PubMed ID: 6260398
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH, Schultz GS.
    Cancer Res; 1984 Aug 01; 44(8):3448-53. PubMed ID: 6331648
    [Abstract] [Full Text] [Related]

  • 12. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G, Wittliff JL, Schally AV.
    Cancer Res; 1995 Jan 15; 55(2):280-7. PubMed ID: 7812958
    [Abstract] [Full Text] [Related]

  • 13. 1,25-Dihydroxyvitamin D3 receptors in human carcinomas: a pilot study.
    Sandgren M, Danforth L, Plasse TF, DeLuca HF.
    Cancer Res; 1991 Apr 15; 51(8):2021-4. PubMed ID: 1849039
    [Abstract] [Full Text] [Related]

  • 14. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
    López-Boado YS, Puente XS, Alvarez S, Tolivia J, Binderup L, López-Otín C.
    Cancer Res; 1997 Sep 15; 57(18):4091-7. PubMed ID: 9307298
    [Abstract] [Full Text] [Related]

  • 15. 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth.
    Freake HC, Marcocci C, Iwasaki J, MacIntyre I.
    Biochem Biophys Res Commun; 1981 Aug 31; 101(4):1131-8. PubMed ID: 6272774
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin.
    Simpson RU, DeLuca HF.
    Proc Natl Acad Sci U S A; 1980 Oct 31; 77(10):5822-6. PubMed ID: 6255467
    [Abstract] [Full Text] [Related]

  • 17. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat.
    Armbrecht HJ, Zenser TV, Davis BB.
    J Clin Invest; 1980 Nov 31; 66(5):1118-23. PubMed ID: 6893596
    [Abstract] [Full Text] [Related]

  • 18. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 31; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 19. Hormone-receptor assays in breast cancer. A five-year experience.
    Mercer RJ, Lie TH, Rennie GC, Bennett RC, Morgan FJ.
    Med J Aust; 1983 Apr 16; 1(8):365-9. PubMed ID: 6835143
    [Abstract] [Full Text] [Related]

  • 20. Presence of 1,25-dihydroxy vitamin D receptor in normal and abnormal breast tissue.
    Eisman JA, Martin TJ, MacIntyre I.
    Prog Biochem Pharmacol; 1980 Apr 16; 17():143-50. PubMed ID: 6259652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.